Press Releases

Date Title and Summary Additional Formats
Toggle Summary Quotient Limited Provides Fourth Quarter and Full Year Fiscal 2021 Results and provides Business Update
New Chief Technology Officer (CTO) appointed to accelerate innovation and further strengthen organizational capabilities Continuing robust progress in advancing the MosaiQ transfusion diagnostics menu Actively preparing for commercialization of MosaiQ products through planned evaluation placements
View HTML
Toggle Summary Quotient Limited to Participate in Upcoming Investor Conferences
JERSEY, Channel Islands , May 31, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the management team will participate in two upcoming investor conferences. Jefferies Virtual Healthcare Conference Date: Wednesday, June 2, 2021
View HTML
Toggle Summary Quotient Limited to Report Fiscal Fourth Quarter and Full Year 2021 Financial Results and Host Conference Call
JERSEY, Channel Islands , May 25, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal fourth quarter and full year ended March 31, 2021 will be released before market open on Tuesday, June 1, 2021 .
View HTML
Toggle Summary Quotient Limited Announces New $95 Million Financing Led by Highbridge
Transaction proceeds will be used to fund the further development of the MosaiQ platform beyond the Donor Lab and the commercial launch of MosaiQ JERSEY, Channel Islands, May 24, 2021 (GLOBE NEWSWIRE) -- Quotient Limited ("Quotient") (NASDAQ: QTNT), a commercial-stage diagnostics company, today
View HTML
Toggle Summary MosaiQ by Quotient Wins Prestigious Red Dot Design Award
JERSEY, Channel Islands , April 12, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced that the company has been recognized with a 2021 Red Dot Product Design Award for the full MosaiQ™ by Quotient system.
View HTML
Toggle Summary Quotient Limited Reports Further Enhanced Multimodal Capabilities of the MosaiQ Technology
Encouraging results from a study of its MosaiQ™ multiplex molecular disease screening (MDS) Microarray MDS product progressing through development Update regarding progress on the Company's MosaiQ expanded Immunohematology (IH) microarray Commercial launch of Expanded IH together with already CE
View HTML
Toggle Summary Quotient Limited Announces Equity Awards
JERSEY, Channel Islands , March 01, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced the scheduled grant of equity awards to Mr. Manuel Mendez , who has been appointed as the Chief Executive Officer of the Company
View HTML
Toggle Summary Quotient Limited to Participate in the Cowen 41st Annual Healthcare Conference
JERSEY, Channel Islands , Feb. 24, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced that the Company will present at the Cowen 41 st Annual Healthcare Conference on Monday, March 1, 2021 at 1:20pm ET .
View HTML
Toggle Summary Quotient Limited Announces Manuel Mendez as Chief Executive Officer
JERSEY, Channel Islands , Feb. 23, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced that Manuel Mendez has been appointed as Chief Executive Officer of the Company and will begin serving in that role on April 1 st , 2021.
View HTML
Toggle Summary Quotient Limited Participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
JERSEY, Channel Islands , Feb. 12, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company (Quotient or the Company), headquartered in Eysins, Switzerland , today announced the Company will participate in the BTIG Virtual MedTech, Digital Health , Life
View HTML